Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Glucocorticoids (GCs) are steroid hormones that exert important physiological actions on metabolism. Given that GCs also exert potent immunosuppressive and anti-inflammatory actions, synthetic GCs such as prednisolone and dexamethasone were developed for the treatment of autoimmune- and inflammatory-related diseases. The synthetic GCs are undoubtedly efficient in terms of their therapeutic effects, but are accompanied by significant adverse effects on metabolism, specifically glucose metabolism. Glucose intolerance and reductions in insulin sensitivity are among the major concerns related to GC metabolic side effects, which may ultimately progress to type 2 diabetes mellitus. A number of pre-clinical and clinical studies have aimed to understand the repercussions of GCs on glucose metabolism and the possible mechanisms of GC action. This review intends to summarize the main alterations that occur in liver, skeletal muscle, adipose tissue, and pancreatic islets in the context of GC-induced glucose intolerance. For this, both experimental (animals) and clinical studies were selected and, whenever possible, the main cellular mechanisms involved in such GC-side effects were discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 8×
“Previous Metabolites 2016, 6, 24 14 of 21 metabolic susceptibility such as that observed in obese, metabolic syndrome and T2DM patients must be taken into account.”
BackgroundInfluentialDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 1×
“These morphological changes in the liver may be due to indirect effects of GCs stimulating lipolysis to elevate circulating FFA levels [75,76], or because of de novo lipogenesis in the liver itself from elevated glucose concentrations [74] (Figure 1).”
BackgroundKern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · cited 1×
“Both plasma TNF-α and IL-6 are associated with hyperinsulinemia [94] and reduced levels have been found to improved insulin sensitivity.”
BackgroundMechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“Adipose-specific 11β-HSD1 over-expression in mice (in subcutaneous and epididymal depots) results in obesity and IR in mice [85], whereas inhibiting 11β-HSD1 enhanced adipose insulin sensitivity [86].”
BackgroundKahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · cited 1×
“Thus, changes in the peripheral insulin sensitivity are reciprocally compensated by changes in circulating insulin levels [98,99].”
BackgroundMechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 1×
“Samuel and Colleagues [80] suggested that PKCε might target the c-Jun N-terminal kinase (JNK)-1 to influence hepatic insulin resistance, although more research is required to determine if there is a connection between the two.”
Background11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969 · cited 1×
“11β-HSD1 is expressed in insulin-target tissues including liver, adipose, and muscles as well as modulating the tissue GC availability [50].”
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731 · cited 3×
“Their central and peripheral actions are well characterized in pathologic conditions of excessive GC secretion, such as in Cushing’s Syndrome, or during GC deficiency, as in Addison’s disease [1,2].”
BackgroundMorton, N. M., Paterson, J. M., Masuzaki, H., Holmes, M. C., Staels, B., Fievet, C., Walker, B. R., Flier, J. S., Mullins, J. J., & Seckl, J. R. (2004) · Diabetes · doi:10.2337/diabetes.53.4.931 · Cited by 512 · cited 1×
“Adipose-specific 11β-HSD1 over-expression in mice (in subcutaneous and epididymal depots) results in obesity and IR in mice [85], whereas inhibiting 11β-HSD1 enhanced adipose insulin sensitivity [86].”
BackgroundA clinical perspective of obesity, metabolic syndrome and cardiovascular disease
Han, T. S., & Lean, M. E. (2016) · JRSM Cardiovascular Disease · doi:10.1177/2048004016633371 · Cited by 500 · cited 1×
“This redistribution and accumulation of body fat centrally and potentially in muscle and liver cells has a significant impact on whole body glucose, lipid and protein metabolism, considering that increased adiposity, specifically at the central depots, is strongly correlated with metabolic syndrome and a marker for in…”
BackgroundLambillotte, C., Gilon, P., & Henquin, J. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119175 · Cited by 419
Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
Szendroedi, J., Yoshimura, T., Phielix, E., Koliaki, C., Marcucci, M., Zhang, D., Jelenik, T., Müller, J., Herder, C., Nowotny, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409229111 · Cited by 415 · cited 11×
“Abbreviations AMPK 51 Adenosine Monophosphate-Activated Kinase cAMP cyclic Adenosine Monophosphate DAG Diacylglycerol DEX Dexamethasone EGP Endogenous Glucose Production FFA Free Fatty Acids FoxO-1 Forkhead Box O-1 GC Glucocorticoid GLUT-4 Glucose Transporter 4 GR Glucocorticoid Receptor GRdim Genetic Engineered Mice…”
BackgroundInfluentialSaad, M. J., Folli, F., Kahn, J. A., & Kahn, C. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116803 · Cited by 349 · cited 2×
“In parallel to GLUT-4 studies, it was shown that five days of DEX treatment, in normal rats, produced no alterations in the insulin-induced insulin receptor and IRS-1 tyrosine phosphorylation in muscles lysates [26].”
BackgroundKang, Y. E., Kim, J. M., Joung, K. H., Lee, J. H., You, B. R., Choi, M. J., Ryu, M. J., Ko, Y. B., Lee, M. A., Lee, J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154003 · Cited by 306 · cited 1×
“Adipokines or adipocytokines are hormones secreted from adipose which influence glucose and lipid metabolism, inflammation, bone remodeling, atherosclerosis, and blood pressure [88].”
BackgroundDirect Effect of Glucocorticoids on Lipolysis in Adipocytes
Xu, C., He, J., Jiang, H., Zu, L., Zhai, W., Pu, S., & Xu, G. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0464 · Cited by 291 · cited 2×
“Additionally, in vitro adipocyte studies have determined that GCs increase cyclic adenosine monophosphate (cAMP) levels and protein kinase A (PKA) content as well as the mRNA expression of two key lipolytic enzymes, hormone-sensitive lipase and adipose triglyceride lipase [32,59].”
BackgroundRuzzin, J., Wagman, A. S., & Jensen, J. (2005) · Diabetologia · doi:10.1007/s00125-005-1886-0 · Cited by 243 · cited 5×
“It was found that 11–12 days of DEX treatment resulted in a diminished ability of insulin to stimulate glucose uptake, glycogen synthesis and glycogen synthase (GS) fractional activity either in soleus and epithroclearis muscles [12].”
BackgroundResultInfluentialAdipogenic and lipolytic effects of chronic glucocorticoid exposure
Campbell, J. E., Peckett, A. J., D'souza, A. M., Hawke, T. J., & Riddell, M. C. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00045.2010 · Cited by 228 · cited 3×
“Additionally, in vitro adipocyte studies have determined that GCs increase cyclic adenosine monophosphate (cAMP) levels and protein kinase A (PKA) content as well as the mRNA expression of two key lipolytic enzymes, hormone-sensitive lipase and adipose triglyceride lipase [32,59].”
BackgroundMethodRafacho, A., Ortsäter, H., Nadal, A., & Quesada, I. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0373 · Cited by 216 · cited 1×
“For a comprehensive review on the non-pancreatic β-cells hormones readers are invited to read [30].”
BackgroundStimulation of Lipolysis in Humans by Physiological Hypercortisolemia
Divertie, G. D., Jensen, M. D., & Miles, J. M. (1991) · Diabetes · doi:10.2337/diab.40.10.1228 · Cited by 201 · cited 1×
“supraphysiological levels of cortisol (6 h infusion) [58], as well as both in vivo in hypercortisolemic rats (300 mg corticosterone for 10 days) [32] and in vitro in isolated rat adipocytes (DEX for 60 min) [59].”
BackgroundBraun, T., Challis, J. R., Newnham, J. P., & Sloboda, D. M. (2013) · Endocrine Reviews · doi:10.1210/er.2013-1012 · Cited by 196 · cited 1×
“, less insulin sensitive and glucose intolerant) in adulthood [110,111].”
BackgroundAcute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men
van Raalte, D. H., Nofrate, V., Bunck, M. C., van Iersel, T., Elassaiss Schaap, J., Nässander, U. K., Heine, R. J., Mari, A., Dokter, W. H. A., & Diamant, M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-1034 · Cited by 170
Lundgren, M., Burén, J., Ruge, T., Myrnäs, T., & Eriksson, J. W. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031157 · Cited by 163 · cited 1×
“In this study, DEX treatment decreased the content of IRS-1 and PKB protein content in omental but not subcutaneous adipocytes [81].”
BackgroundRoles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes.
Ogawa, A., Johnson, J. H., Ohneda, M., McAllister, C. T., Inman, L., Alam, T., & Unger, R. H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115886 · Cited by 159 · cited 1×
“It was shown that Zucker rats exposed to high doses of DEX develop significant insulinopenia [123].”
BackgroundInsulin Resistance in Cushing’s Syndrome*
NOSADINI, R., DEL PRATO, S., TIENGO, A., VALERIO, A., MUGGEO, M., OPOCHER, G., MANTERO, F., DUNER, E., MARESCOTTI, C., MOLLO, F., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-3-529 · Cited by 146 · cited 1×
“GCs are well known to induce alterations in glucose homeostasis and impairments in glucose tolerance are amongst the common adverse effects during GC therapies [2], as well as in patients with Cushing’s syndrome [21].”
BackgroundAdditive effects of cortisol and growth hormone on regional and systemic lipolysis in humans
Djurhuus, C. B., Gravholt, C. H., Nielsen, S., Pedersen, S. B., Møller, N., & Schmitz, O. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00199.2003 · Cited by 131 · cited 1×
“GCs have consistently been shown to increase the rate of lipolysis via increased expression of adipose tissue lipases, which results in the release of glycerol and FFA into the circulation (Figure 1) [57].”
BackgroundInsulin action and signalling in fat and muscle from dexamethasone-treated rats
Burén, J., Lai, Y. C., Lundgren, M., Eriksson, J. W., & Jensen, J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.034 · Cited by 125 · cited 15×
“Abbreviations AMPK 51 Adenosine Monophosphate-Activated Kinase cAMP cyclic Adenosine Monophosphate DAG Diacylglycerol DEX Dexamethasone EGP Endogenous Glucose Production FFA Free Fatty Acids FoxO-1 Forkhead Box O-1 GC Glucocorticoid GLUT-4 Glucose Transporter 4 GR Glucocorticoid Receptor GRdim Genetic Engineered Mice…”
BackgroundMethodResultInfluentialMetabolic Adaptations to Dexamethasone‐Induced Insulin Resistance in Healthy Volunteers
Nicod, N., Giusti, V., Besse, C., & Tappy, L. (2003) · Obesity Research · doi:10.1038/oby.2003.90 · Cited by 125
van Raalte, D. H., Brands, M., van der Zijl, N. J., Muskiet, M. H., Pouwels, P. J. W., Ackermans, M. T., Sauerwein, H. P., Serlie, M. J., & Diamant, M. (2011) · Diabetologia · doi:10.1007/s00125-011-2174-9 · Cited by 109 · cited 3×
“For longer periods of GC treatment in humans, for instance, 2–4 days with DEX or 6–15 days with PRED, β-cell function adapts to compensate, at least in parts, to the peripheral IR caused by GCs [9,10,17,31,35].”
BackgroundWajngot, A., Giacca, A., Grill, V, Vranic, M., & Efendic, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6035 · Cited by 105
Rafacho, A., Marroquí, L., Taboga, S. R., Abrantes, J. L. F., Silveira, L. R., Boschero, A. C., Carneiro, E. M., Bosqueiro, J. R., Nadal, A., & Quesada, I. (2010) · Endocrinology · doi:10.1210/en.2009-0704 · Cited by 80 · cited 5×
“, increased islet nicotinamide adenine dinucleotide phosphate generation, and enhanced mitochondrial function and intracellular calcium in response to glucose) [115].”
BackgroundInfluentialSelf-citationHaber, R. S., & Weinstein, S. P. (1992) · Diabetes · doi:10.2337/diab.41.6.728 · Cited by 77 · cited 3×
“The contribution of glucose transporter (GLUT)-4, a protein recruited to the cell surface in response to insulin plays a major role in the stimulation of glucose transport into skeletal muscles in rats treated with DEX [7,43,45,46].”
BackgroundResultA rodent model of rapid-onset diabetes (ROD) induced by glucocorticoids and high-fat feeding
Shpilberg, Y., Beaudry, J. L., D'Souza, A., Campbell, J. E., Peckett, A., & Riddell, M. C. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.008912 · Cited by 77
Troglitazone Antagonizes Metabolic Effects of Glucocorticoids in Humans
Willi, S. M., Kennedy, A., Wallace, P., Ganaway, E., Rogers, N. L., & Garvey, W. T. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2895 · Cited by 77
Larsson, H., & Ahrén, B. (1999) · Diabetologia · doi:10.1007/s001250051251 · Cited by 73
Jeong, I.-K., Oh, S.-H., Kim, B.-J., Chung, J.-H., Min, Y.-K., Lee, M.-S., Lee, M.-K., & Kim, K.-W. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00229-1 · Cited by 71
den Uyl, D., van Raalte, D. H., Nurmohamed, M. T., Lems, W. F., Bijlsma, J. W. J., Hoes, J. N., Dijkmans, B. A. C., & Diamant, M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33378 · Cited by 70
Hollingdal, M., Juhl, C. B., Dall, R., Sturis, J., Veldhuis, J. D., Schmitz, O., & Pørksen, N. (2002) · Diabetologia · doi:10.1007/s125-002-8244-y · Cited by 67
β-cell adaptation in a mouse model of glucocorticoid-induced metabolic syndrome
Fransson, L., Franzén, S., Rosengren, V., Wolbert, P., Sjöholm, Å., & Ortsäter, H. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0189 · Cited by 59
Besse, C., Nicod, N., & Tappy, L. (2005) · Obesity Research · doi:10.1038/oby.2005.41 · Cited by 40
Analysis of Insulin Sensitivity in Adipose Tissue of Patients with Primary Aldosteronism
Urbanet, R., Pilon, C., Calcagno, A., Peschechera, A., Hubert, E.-L., Giacchetti, G., Gomez-Sanchez, C., Mulatero, P., Toffanin, M., Sonino, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0097 · Cited by 38
Feng, B., He, Q., & Xu, H. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.001 · Cited by 37
Cited by
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Li, H., Cai, J., Chen, R., Zhao, Z., Ying, Z., Wang, L., Chen, J., Hao, K., Kinney, P. L., Chen, H., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026796 · Cited by 521
Steroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative review
Bonaventura, A., & Montecucco, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.006 · Cited by 108
Polydeoxyribonucleotide Regulation of Inflammation
Colangelo, M. T., Galli, C., & Guizzardi, S. (2020) · Advances in Wound Care · doi:10.1089/wound.2019.1031 · Cited by 33
Jiang, R., Wang, M., Shi, L., Zhou, J., Ma, R., Feng, K., Chen, X., Xu, X., Li, X., Li, T., et al. (2019) · BioMed Research International · doi:10.1155/2019/3719643 · Cited by 27
“However, excess DEX leads to defects in glucose metabolism, muscle atrophy, and insulin resistance [4, 5].”
Background
Metadata
- Authors
- Pasieka, A., & Rafacho, A.
- Venue
- Metabolites
- Publisher
- MDPI AG
- Published
- 2016-08-03
- Volume
- 6
- Issue
- 3
- Pages
- 24
- ISSN
- 2218-1989 (ISSN-L)
- OpenAlex
- W2485845712
- Cited by
- 90
- References
- 42
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.